Westmore · UDRP decision
WIPO · Case No. D2025-1535

Sanofi-us.com

TransferWIPO-indexed · informational, not legal advice

The Panel ordered transfer of <sanofi-us.com> to Sanofi. It found the domain confusingly similar to the SANOFI trademark because it incorporated the mark in full with the geographic acronym “US.” The Respondent did not rebut Sanofi’s prima facie case on rights or legitimate interests, and the domain’s composition and redirection to Sanofi’s official U.S. website were inherently misleading. Bad faith was established from the targeting of the famous and distinctive SANOFI mark, the Respondent’s continued control over the redirection, and the apparent use of a third party’s physical address in the registration details.

Outcome
Transfer
At a glance
Provider
WIPO
Outcome
Transfer
Decision date
2025-06-18
Panelist(s)
Jarka, Beatrice O.
Complainant
Sanofi
Respondent
Brandon Seppelt
Counsel
Selarl Marchais · associés
Disputed domain(s)
sanofi-us.com
Domain history UDRP Intelligence

The timeline behind sanofi-us.com

Registration, the decision and the archived record of what this domain actually displayed — from public RDAP and the Internet Archive.

Westmore reconstructs the full history behind sanofi-us.com — from public RDAP and the Internet Archive — as part of UDRP Intelligence:

Registration → decision → today timeline
Archived Wayback evidence of what the site showed
Registry bad-faith signals
The live current registrant
Available in UDRP Intelligence
Verified public record
Outcome & remedy
Complaint granted. Panel ordered transfer of sanofi-us.com.
Reverse Domain Name Hijacking
No RDNH raised.
Westmore Insight

The decision illustrates that redirecting a trademark-formative domain to the trademark owner’s own website does not create a legitimate interest and may instead support bad faith. The Panel emphasized that the registrant retains control over the redirection, creating a real or implied ongoing threat even where users presently reach the legitimate website.

The three-part test
Identical or Confusingly SimilarMet
Rights or Legitimate InterestsMet
Registered and Used in Bad FaithMet

Result of record. The panel's reasoning and decisive facts behind each element are in the Intelligence dossier below.

Case details
Provider
WIPO
Outcome
Transfer
Decision date
2025-06-18
Panel
Jarka, Beatrice O.
Full decision
10 min read · hosted by Westmore

ARBITRATION AN D MEDIATION CENTER ADMINISTRATIVE PANEL DECISION Sanofi v. Brandon Seppelt Case No. D2025-1535 1. The Parties The Complainant is Sanof i, France, represented by Selarl Marchais & Associés, France. The Respondent is Brandon Seppelt, United States of America (“U.S.”). 2. The Domain Name and Registrar The disputed domain name <sanofi-us.com> is registered with Hosting Concepts B.V. d/b/a Registrar.eu. (the “Reg istrar”). 3. Procedural History The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on April 15, 2025. On April 16, 2025, the Center transmitted by email to the Registrar a request f or registrar verif ication in connection with the disputed domain name. On April 16, 2025, the Registrar transmitted by email to the Center its verif ication response disclosing registrant and contact information for the disputed domain name which differed from the named Respondent (REDACTED FOR PRIVACY) and contact inf ormation in the Complaint. The Center sent an email communication to the Complainant on April 28, 2025, providing the registrant and contact information disclosed by the Registrar, and inviting the Complainant to submit an amendment to the Complaint. The Complainant f iled an amendment to the Complaint on May 5, 2025. The Center verif ied that the Complaint together with the amendment to the Complaint satisf ied the f ormal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy” or “UDRP”), the Rules f or Unif orm Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules f or Unif orm Domain Name Dispute Resolution Policy (the “Supplemental Rules”). In accordance with the Rules, paragraphs 2 and 4, the Center f ormally notif ied the Respondent of the Complaint, and the proceedings commenced on May 6, 2025. In accordance with the Rules, paragraph 5, the due date for Response was May 26, 2025. The Respondent did not submit any response. On May 15, 2025, a third party email communication was received by the Center. On May 27, 2025, the Center informed the Parties of the commencement of panel appointment. page 2 The Center appointed Beatrice Onica Jarka as the sole panelist in this matter on June 4, 2025. The Panel f inds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7. 4. Factual Background The Complainant in these proceedings is Sanof i ranking 4th world’s largest multinational pharmaceutical company by prescription sales. The Complainant engages in research and development (R&D), manuf acturing and marketing of pharmaceutical products for sale, principally in the prescription market, but the Complainant also develops over-the-counter medication. With an R&D investment of EUR 6.7 billion in 2022, the Complainant’s R&D portf olio includes 84 projects in clinical development, 26 of which are at advanced stages. The Complainant appears to be worldwide recognized. The Complainant is the owner of the f ollowing SANOFI trademarks, among others: − French trademark SANOFI number 96655339, registered on January 17, 1997 in classes 1, 3, 5, 9, 10, 35, 40, and 42; − European Union trademark SANOFI number 010167351, f iled on August 2, 2011 and registered on January 7, 2012 in classes 3 and 5; and − International trademark SANOFI number 1091805, registered on August 18, 2011, in classes 1, 3, 5, 9, 10, 16, 35, 38, 40, 41, 42, and 44 designating among others Georgia, Russian Federation, Ukraine. The Complainant is also the owner of the f ollowing domain names among others: − <sanof i.com> registered on October 13, 1995; − <sanof i.eu> registered on March 12, 2006; and − <sanof i.f r> registered on October 10, 2006; The Respondent in these proceedings is reportedly located in the U.S. The disputed domain name was registered on March 30, 2025, and redirects to the Complainant’s of f icial U.S. website. 5. Parties’ Contentions A. Complainant The Complainant contends that it has satisfied each of the elements required under the Policy f or a transf er of the disputed domain name. Notably, the Complainant contends that: - the disputed domain name comprises of an exact reproduction of the Complainant’s trademark SANOFI, which is a highly distinctive trademark combined with a geographic acronym – “US” – followed by a Top-Level Domain suf f ix. - the Respondent has no prior rights and/or legitimate interests to justify the use of SANOFI trademarks in the disputed domain name and no relationship whatsoever exists between the Complainant and the Respondent. - the disputed domain name redirects to the Complainant’s official website without authorization and is theref ore being used as a phishing domain name to send emails using the SANOFI trademarks in the email address, namely “@sanof i-us.com”. page 3 - the Respondent registered the disputed domain name in bad f aith corresponding to the trademarks and domain names owned by the Complainant, as this behavior can in no way be the result of a mere coincidence, given the f amous and distinctive nature of the SANOFI trademark. - the Respondent has registered and used the disputed domain name only f or the purpose of unf airly attracting Internet users to the Respondent’s website which f urther redirects to the Complainant’s of f icial U.S. website, being used as a phishing domain name to send emails using the SANOFI trademarks in the email address, namely “@sanof i-us.com”. - the lack of apparent genuine use of the disputed domain name particularly close to those used by the Complainant is likely to cause irreparable prejudice to the Complainant’s general goodwill because Internet users could be led to believe that the Complainant is not on the Internet or worse that the Complainant is out of business. B. Respondent Although being properly notif ied of the Complaint, the Respondent did not reply to the Complainant’s contentions. On May 15, 2025, a third party contacted the Center indicating that they received the Written Notice addressed to the Respondent, however, there is no one by that name at their organization. 6. Discussion and Findings A. Identical or Confusingly Similar It is well accepted that the f irst element f unctions primarily as a standing requirement. The standing (or threshold) test for confusing similarity involves a reasoned but relatively straightforward comparison between the Complainant’s trademark and the disputed domain name. WIPO Overview of WIPO Panel Views on Selected UDRP Questions, Third Edition (“WIPO Overview 3.0”), section 1.7. The Complainant has shown rights in respect of the SANOFI trademark f or the purposes of the Policy. WIPO Overview 3.0, section 1.2.1. The Panel considers, as other panels, that SANOFI is a highly distinctive trademark. The Panel f urther notes that the entirety of the SANOFI mark is reproduced within the disputed domain name. It is the disputed domain name which comprises of an exact reproduction of the Complainant’s worldwide recognized trademark SANOFI combined with a geographic acronym – “US” - f ollowed by a Top-Level Domain suf f ix. The element (here, “US”) added to the SANOFI trademark does not prevent a f inding of conf using similarity between the disputed domain name and the mark f or the purposes of the Policy. WIPO Overview 3.0, section 1.8. Accordingly, the disputed domain name is conf usingly similar to the mark f or the purposes of the Policy (WIPO Overview 3.0, section 1.7), and the Panel finds the first element of the Policy has been established. B. Rights or Legitimate Interests Paragraph 4(c) of the Policy provides a list of circumstances in which the Respondent may demonstrate rights or legitimate interests in a disputed domain name. Although the overall burden of proof in UDRP proceedings is on the complainant, panels have recognized that proving a respondent lacks rights or legitimate interests in a domain name may result in the difficult task of “proving a negative”, requiring information that is of ten primarily within the knowledge or control of the respondent. As such, where a complainant makes out a prima facie case that the respondent lacks rights or legitimate interests, the burden of production on this element shifts to the respondent to come f orward with page 4 relevant evidence demonstrating rights or legitimate interests in the domain name (although the burden of proof always remains on the complainant). If the respondent f ails to come f orward with such relevant evidence, the complainant is deemed to have satisf ied the second element. WIPO Overview 3.0, section 2.1. Having reviewed the available record, the Panel finds the Complainant has established a prima f acie case that the Respondent lacks rights or legitimate interests in the disputed domain name. Although being properly notified of the Complaint, the Respondent has not rebutted the Complainant’s prima f acie showing and has not come f orward with any relevant evidence demonstrating rights or legitimate interests in the disputed domain name such as those enumerated in the Policy or otherwise. The Panel notes that the composition of the disputed domain name is inherently misleading, together with the use of the disputed domain name redirecting to the Complainant’s off icial website, which creates a risk that Internet users may think that the disputed domain name belongs to the Complainant. Accordingly, the Panel f inds the second element of the Policy has been established. C. Registered and Used in Bad Faith The Panel notes that, f or the purposes of paragraph 4(a)(iii) of the Policy, paragraph 4(b) of the Policy establishes circumstances, in particular, but without limitation, that, if found by the Panel to be present, shall be evidence of the registration and use of a domain name in bad f aith. Paragraph 4(b) of the Policy sets out a list of non-exhaustive circumstances that may indicate that a domain name was registered and used in bad faith, but other circumstances may be relevant in assessing whether a respondent’s registration and use of a domain name is in bad f aith. WIPO Overview 3.0, section 3.2.1. In the present case, the Panel notes that the Respondent: - the Respondent registered the disputed domain name in bad f aith corresponding to the trademarks and domain names owned by the Complainant, while targeting the Complainant, given the famous and distinctive nature of the SANOFI trademark. - the Respondent has registered and used the disputed domain name only f or the purpose of unf airly attracting Internet users to the Respondent’s website which f urther redirects to the Complainant’s of f icial U.S. website. Panels have f ound that a respondent redirecting a domain name to the complainant’s website can establish bad f aith insof ar as the respondent retains control over the redirection thus creating a real or implied ongoing threat to the complainant. WIPO Overview 3.0, section 3.1.4. Moreover, the bad faith behavior of the Respondent is further documented by the indication of the email from a third party to the Center dated May 15, 2025, regarding the apparent use of this third p arty’s physical address when registering the disputed domain name. Accordingly, the Panel f inds that the Complainant has established the third element of the Policy. 7. Decision For the f oregoing reasons, in accordance with paragraphs 4(i) of the Policy and 15 of the Rules, the Panel orders that the disputed domain name <sanof i-us.com> be transf erred to the Complainant. /Dr. Beatrice Onica Jarka/ Dr. Beatrice Onica Jarka Sole Panelist Date: June 18, 2025

Source of record: WIPO . Reproduced for research; WIPO is the authoritative source.

Beyond the decision

What Westmore sees around sanofi-us.com

The decision is only the record. Westmore connects it to the cases, authorities, panelists, parties and domain evidence surrounding it.

Connected to Westmore UDRP Intelligence
115,979 decisions · citations · panelists · parties · domain history
Eleanor · UDRP intelligence
Ask Eleanor about this decision
Ask Eleanor about this decision

A short, grounded explanation drawn only from this decision's record — not legal advice or a prediction.

Unlocking Eleanor for this case uses 1 of your complimentary Intelligence unlocks· 3 remaining

Grounded in the Westmore record for this decision. Research/informational only — not legal advice or a prediction of any outcome.

Westmore Professional · Unlock the intelligence

The decision is only the beginning.

You've seen what happened. Now discover the deeper intelligence behind the case, the panelist, the parties and the authorities that matter.

Citation Intelligence
How this decision is cited and treated across the corpus.
Panelist Intelligence
The panel's tendencies, outcomes and reasoning patterns.
Domain History
Ownership chronology — creation vs. respondent acquisition.
Opposing-Party Research
Complainant, counsel and portfolio context.
Independent Case Review
Eleanor challenges your filing before the other side does.
Professional Matters
Open, research and manage matters end to end.
$395/month
Unlock Westmore Professional Annual & firm seats available · cancel anytime
Take the next step
Westmore UDRP · find the right service

Westmore UDRP records draw on WIPO-indexed decisions and are provided for research and informational purposes only. Not legal advice, a clearance opinion, or a prediction of any outcome.

Essential cookies only. Nothing is sold or shared.